Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Increases Bilophila - : lactobacillus rhamnosus gg (probiotics) |
📓
Lactobacillus rhamnosus GG protects against atherosclerosis by improving ketone body synthesis. Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 106 Issue 24 Pages: 8233-8243 Pub: 2022 Dec Epub: 2022 Nov 17 Authors Zhai T , Ren W , Wang P , Zheng L , Publication |
Decreases Bilophila - : lactobacillus rhamnosus gg (probiotics) |
📓
A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in Apc<sup>Min/+</sup> mice. Journal of applied microbiology (J Appl Microbiol ) Vol: 122 Issue 3 Pages: 770-784 Pub: 2017 Mar Epub: 2017 Jan 30 Authors Ni Y , Wong VH , Tai WC , Li J , Wong WY , Lee MM , Fong FL , El-Nezami H , Panagiotou G , Publication |
Decreases Bilophila - : lactobacillus rhamnosus gg (probiotics) |
👶
A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in Apc<sup>Min/+</sup> mice. Journal of applied microbiology (J Appl Microbiol ) Vol: 122 Issue 3 Pages: 770-784 Pub: 2017 Mar Epub: 2017 Jan 30 Authors Ni Y , Wong VH , Tai WC , Li J , Wong WY , Lee MM , Fong FL , El-Nezami H , Panagiotou G , Publication |
Decreases Bilophila - : lactobacillus rhamnosus gg (probiotics) |
👪
A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in Apc<sup>Min/+</sup> mice. Journal of applied microbiology (J Appl Microbiol ) Vol: 122 Issue 3 Pages: 770-784 Pub: 2017 Mar Epub: 2017 Jan 30 Authors Ni Y , Wong VH , Tai WC , Li J , Wong WY , Lee MM , Fong FL , El-Nezami H , Panagiotou G , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.